Hunter C. Smith
CFO & TreasurerMr. Hunter C. Smith, M.B.A., has been the Chief Financial Officer at Rhythm Pharmaceuticals, Inc. since July 31, 2017 and serves as its Treasurer since August 2017 respectively. He serves as Director at Vanqua Bio, Inc. since 2024. He had been an Independent Director of Aeglea BioTherapeutics, Inc. since November 12, 2021 until November 22, 2023. Mr. Smith was an Interim President and Chief Executive Officer at Rhythm Pharmaceuticals, Inc. since March 28, 2020 until July 20, 2020. He served as Secretary of Rhythm Pharmaceuticals, Inc. since April 2020 until March 2021. Mr. Smith has been the Chief Financial Officer of Rhythm Holding Company, LLC since August 1, 2017. He has more global finance and management experience across multiple industries and financial disciplines, including expertise in business analysis and planning, mergers and acquisitions, treasury, capital raising and Investor Relations. Mr. Smith served as Vice President of Finance and Chief Financial Officer of the Inflammation and Immunology Business Unit of Celgene Corporation from 2013 to July 2017. Mr. Smith provided finance leadership for the global launch of Otezla®, co-led the integration of Receptos, Inc. following its acquisition by Celgene and led global business planning and analysis for commercial affiliates and clinical study activities in over 16 countries. He held various roles during (1999 to 2013) at Bunge Limited, including and Chief Financial Officer of Bunge’s Sugar and Bioenergy Segment, Corporate Treasurer and Chief Risk Officer. He served as Regional Chief Financial Officer for Asia at Bunge Limited since July 21, 2003 and its Director of Investor Relations and Global Communications. He served as the Chief Financial Officer of Bunge's Sugar and Bioenergy Segment Until its acquisition by Brookfield Infrastructure Partners in December 2019. He joined Bunge in 1998 as Assistant Treasurer. He started his career at Manufacturers Hanover Trust Company. Mr. Smith serves on the Board of Directors of Vanqua Bio and Avidicure BV. He has been an Independent Director of Genessee & Wyoming Inc. since March 27, 2015. He served as a Director of UBS AG. Mr. Smith has a B.A. in History, with honors, from Northwestern University and MBA in Finance from the Stern School of Business at New York University.
Positions
- Company NameRhythm Pharmaceuticals, Inc.Stock CodeRYTMPositionCFO & TreasurerColleagues
- DPDavid P. MeekerChairman, President & CEO
- AGAlastair GarfieldChief Scientific Officer
- YMYann MazabraudExecutive VP & Head of International
- JLJennifer LeeExecutive VP & Head of North America
- DWDavid W. J. McGirrIndependent Director
- LMLee M. KaplanChairman of Scientific Advisory Board
- SAStuart A. ArbuckleIndependent Director
- LALynn A. TetraultIndependent Lead Director
